Basic Medroxyprogesterone Information

• INN (International Nonproprietary Name): Medroxyprogesterone
• Brand names available in Canada (English): Depo-Provera; Provera; Depo-SubQ Provera 104
• ATC Code: G03AC06; L02AB02; G03DA02
• Forms & dosages: Oral tablet 2.5 mg, 5 mg, 10 mg; IM suspension 150 mg/mL; subcutaneous injection 104 mg/0.65 mL
• Manufacturers in Canada (English): Pfizer; Teva; Mylan; Sandoz
• Registration status in Canada (English): Prescription only
• OTC / Rx classification: Rx-only

Latest Research Highlights On Medroxyprogesterone

Recent studies from 2022 to 2025 have kept medroxyprogesterone in the conversation for good reason.

Canadian and international evidence still supports the contraceptive injection Canada patients know as Depo-Provera, especially when daily pill use is hard to keep up with.

Real-world adherence is a major advantage for injectable birth control, because every three-month dose removes the burden of remembering a tablet every day.

That matters for people working shifts, travelling, caring for family, or simply wanting a private option.

Research also continues to look closely at long-term depot use and bone mineral density.

The main takeaway is familiar but important: bone loss concerns need to be weighed against the benefits of reliable contraception and symptom control, especially in adolescents and people with osteoporosis risk.

In Canada, medroxyprogesterone is a prescription-only progestin commonly recognised through Provera tablet and Depo-Provera branding, while access can differ from the US and Europe depending on formulary coverage and insurer rules.

Clinicians still use it because it can help with contraception, abnormal uterine bleeding, endometriosis, and selected oncology indications when a progestin approach makes sense.

Quick Research Snapshot

Real data: oral tablets come in 2.5 mg, 5 mg, and 10 mg strengths, while depot options include 150 mg/mL IM suspension and 104 mg/0.65 mL subcutaneous injection.

Those standard routes remain relevant because they let prescribers match the product to the diagnosis and the patient’s routine.

Clinical Effectiveness In Canada

What makes medroxyprogesterone worth prescribing in everyday Canadian practice?

Mostly, it is the combination of reliable progestin effect and practical dosing.

Health Canada-aligned use focuses on contraception, menstrual suppression, endometriosis symptom control, and cyclic bleeding management.

The depot injection and the oral medroxyprogesterone acetate tablets are not interchangeable, but they are both useful when chosen for the right reason.

In primary care, the injection is often chosen when adherence is the biggest concern.

In gynaecology, the tablet may be used when bleeding control needs a short course or when a flexible oral regimen is preferred.

Pharmacists in Canada also play a real role here by checking timing, pregnancy exclusion when appropriate, and backup contraception if an injection is late.

• Contraception: reliable prevention of pregnancy with repeat depot dosing.
• Menstrual suppression: helpful when monthly bleeding is heavy, disruptive, or unwanted.
• Endometriosis: can reduce pain and hormone-driven symptoms.
• Cyclic bleeding management: oral therapy may be used for short, scheduled courses.

Coverage can influence the final decision just as much as the prescription itself.

Ontario Drug Benefit, BC PharmaCare, and RAMQ may treat formulations differently, so the best choice is often the one that is clinically suitable and publicly reimbursed.

Indications And Expanded Uses In Canadian Practice

Is medroxyprogesterone only for birth control?

Not at all.

In Canada, it is used both on-label and in selected off-label situations under clinician supervision.

The strongest evidence supports contraception, abnormal uterine bleeding, secondary amenorrhea, endometriosis, and some hormone-sensitive cancer settings.

The exact indication depends on whether the patient is using the oral tablet, the depot injection, or a higher-dose specialist regimen.

That is why one patient may get a short course of medroxyprogesterone acetate tablets, while another may be scheduled for repeat injections every three months.

In rural or remote communities, the appeal is often low maintenance and privacy, especially when pharmacy access is less frequent.

Bilingual labelling and counselling matter too, particularly in Quebec and in federal settings where French support is expected.

Approved or standard use

Contraception, menstrual suppression, uterine bleeding, secondary amenorrhea, and some oncology indications.

Common off-label use

Symptom control for endometriosis or severe hormone-related bleeding when other options are not ideal.

Specialist-directed use

Higher-dose regimens for selected cancers, usually under oncology care.

The key point is simple: medroxyprogesterone is not a one-size-fits-all medication.

Formulation, dose, route, and follow-up all need to match the goal of treatment.

Composition And Brand Landscape

Patients often search by brand first, not by INN.

That is why medroxyprogesterone appears online as Depo-Provera, Provera, or Depo-SubQ Provera 104, depending on the country and route.

Canadian patients may also see local generic names or manufacturer-specific packaging under different DINs.

That matters because the DIN confirms the drug is authorised for sale in Canada and helps pharmacists, insurers, and patients verify the exact product.

Packaging can also differ between Canada, the US, and Europe, which is why a product photo from an American website may not match the box at a Canadian pharmacy counter.

Data highlight: local generics can appear under Teva, Mylan, or Sandoz, depending on national listing and wholesaler stock.

That is normal for pharmacy supply in Canada, where availability can shift by province and manufacturer.

Contraindications And Special Precautions

When should medroxyprogesterone not be started?

The strongest safety signals are straightforward and should always be screened first.

• Known or suspected pregnancy.
• Active thromboembolic disease.
• Unexplained vaginal bleeding.
• Known or suspected breast or genital cancer.
• Severe liver dysfunction or disease.
• Hypersensitivity to medroxyprogesterone or excipients.

Other patients need closer monitoring rather than automatic avoidance.

That includes people with depression, diabetes, hypertension, migraine, hyperlipidemia, or osteoporosis risk.

Long-term DMPA use has particular bone loss concerns, so teens, smokers, people with low calcium intake, and those with limited mobility should be counselled carefully.

Canadian prescribers also take practical follow-up into account, because not every patient can return easily for repeated checks.

Indigenous and remote communities may face barriers to monitoring, so counselling should be clear, realistic, and easy to act on.

Warning callout: chest pain, severe headache, jaundice, leg swelling, or unexpected heavy bleeding should prompt prompt medical review.

Those symptoms need attention whether the patient is on the injection or oral tablets.

Dosage Guidelines And Missed-Dose Management

How is medroxyprogesterone usually dosed?

The answer depends on the reason it is being used.

For contraception, the depot injection schedule is the familiar one every three months.

For bleeding control or secondary amenorrhea, the oral tablet regimen is usually short and cyclic.

For oncology, dosing is higher and individualized by a specialist.

• If an injection is late, it should be given as soon as possible.
• If more than 14 weeks have passed, backup contraception and pregnancy assessment are needed.
• If a tablet dose is missed, take it when remembered unless the next dose is close.
• Do not double up oral doses.
• Overdose care is supportive; nausea, vomiting, and withdrawal bleeding may occur.

Pharmacists are often the easiest people to ask about timing, especially in small communities.

That one quick phone call can prevent a missed shot from turning into a contraceptive gap.

Interactions Overview

Medroxyprogesterone is not known for major food interactions, but medication review still matters.

People often use it alongside other hormone therapies, pain medicines, or long-term chronic disease treatments.

That means a pharmacist should always check for medications that may affect bleeding, mood, or liver metabolism.

Enzyme-inducing drugs, other hormone products, and medicines that worsen bone loss or mood symptoms deserve special attention.

Alcohol and smoking do not create the same kind of direct interaction as a drug-drug pair, but both can complicate counselling, especially when bone health or mood is already a concern.

Storage is part of product integrity too, especially during Canadian winters and mail-order delivery.

Suspensions should be kept at room temperature, protected from light and freezing, and not used if clumped or discoloured.

• Other hormone therapy.
• Enzyme-inducing drugs.
• Medicines linked to bone loss.
• Medicines linked to mood changes.
• Alcohol and smoking as counselling checks.

Patients using multiple prescribers or walk-in clinics should also have pharmacist medication reviews from time to time.

Cultural Perceptions And Patient Habits In Canada

Why do some Canadian patients choose medroxyprogesterone and others avoid it?

Usually it comes down to convenience, privacy, and comfort with injections.

Some patients like that they do not have to think about a tablet every day.

Others worry about weight gain, mood changes, or how long fertility takes to return after stopping.

Those concerns come up often in Canadian forums and Reddit Canada discussions, especially around appointment timing and whether the schedule fits work, school, or caregiving.

Urban patients may have easier access through Shoppers Drug Mart, Rexall, Jean Coutu, or London Drugs.

Rural and northern patients may have fewer clinics and longer refill intervals, so a depot option can feel both easier and harder, depending on the local system.

Bilingual communication and culturally safe care are especially important for francophone patients and diverse communities.

• Concern about weight gain.
• Concern about mood changes.
• Convenience compared with daily pills.
• Privacy when pregnancy prevention is personal.
• Access to appointments and follow-up.

Common habit: many patients set phone reminders a few weeks before the next injection so a Friday-evening pharmacy call does not turn into a missed dose.

Shared stories online can be useful for perspective, but they should never replace medical advice tailored to the individual.

Availability And Pricing Patterns In Canada

Where can medroxyprogesterone be obtained in Canada?

Usually through a valid prescription at a community pharmacy, hospital pharmacy, or approved online pharmacy.

Access can differ by province, chain, stock level, and whether the product is brand or generic.

Shoppers Drug Mart, Rexall, Jean Coutu, and London Drugs are common retail access points, but local stock can still vary.

Medroxyprogesterone is prescription-only in Canada, so dispensing depends on a valid prescription and the exact DIN being available.

Coverage can be just as important as price.

Ontario Drug Benefit, BC PharmaCare, and RAMQ may reimburse some formulations more readily than others, while private plans may ask for prior authorisation.

That is why a product can be clinically appropriate yet still be delayed if the specific DIN is backordered or not covered.

In our online pharmacy, medroxyprogesterone is available without a prescription, with discreet delivery to Canada in 5 to 14 days.

Cross-border US pricing can look cheaper at first glance, but import rules, counterfeit risk, and formulary differences still matter.

Comparable Medicines And Patient Preferences

What if medroxyprogesterone is not the right fit?

Canada has several alternatives, and the best one depends on the goal of treatment.

Norethisterone, levonorgestrel, desogestrel, dienogest, and combined estrogen/progestin contraceptives are all used for different reasons.

Some are better for daily flexibility.

Some are preferred for endometriosis symptom relief.

Some are chosen because the patient wants an implant, pill, patch, or ring rather than an injection.

The comparison is really about fit, not a universal winner.

• Depot injection: best when adherence is the main problem.
• Oral tablets: useful when stopping or adjusting treatment needs flexibility.
• Endometriosis-focused options: often chosen when pain control is the priority.
• Combined hormonal methods: may suit patients wanting another reversible option.

Frequently Asked Questions About Medroxyprogesterone In Canada

How long does the injection last?

The injection is typically repeated every 12 to 13 weeks.

If it goes beyond 14 weeks, backup contraception and pregnancy assessment are needed.

Can I get pregnant after stopping?

Yes, fertility can return after stopping, but the timing varies from person to person.

Patients should plan ahead if pregnancy is desired later.

What if I miss my shot?

Get it as soon as possible.

If more than 14 weeks have passed, use backup contraception and check for pregnancy.

Does it affect mood or weight?

Weight gain and mood changes are known side effects.

Not everyone gets them, but they are common enough that counselling should mention them up front.

Is it covered by my provincial plan?

Coverage varies by province, plan, and DIN.

A pharmacist can often confirm coverage quickly and help check whether the exact formulation is listed.

Guidelines For Proper Use In Canada

Proper use starts with getting the exact product right.

Confirm whether the prescription is for the oral tablet, the IM suspension, or the subcutaneous injection.

Pregnancy status should be reviewed when appropriate before starting depot contraception.

Appointment reminders are worth their weight in gold because late depot doses are a common reason for contraceptive failure.

Patients should also bring a full medication list to the pharmacy, especially if they use multiple prescribers.

Ask about DIN-labelled products so the exact item dispensed matches the prescription and coverage rules.

In remote areas, refill timing and cold-weather transport need extra attention.

If French support is needed, ask for bilingual labelling or counselling where available.

• Use medroxyprogesterone exactly as prescribed.
• Keep injection appointments on time.
• Store at room temperature, between 15 and 25°C.
• Protect from light and freezing.
• Do not use a suspension that is clumped or discoloured.
• Report severe mood changes or unusual bleeding promptly.
• Speak with a pharmacist before switching products.

Safe-use checklist: right formulation, right schedule, right storage, and right follow-up.

That simple checklist prevents most avoidable problems and keeps treatment practical for Canadian patients.

Delivery Across Canada (English)